Catalent
Company Information
As of 10/26/22
Country
U.S.
Headquarters
Somerset, N.J.
Industry
Pharmaceuticals
CEO
Alessandro Maselli
Website
Company Type
Public
Ticker
CTLT
Revenues ($M)
$4,703
Profits ($M)
$513
Market Value ($M)
$13,377
Employees
17,300
Revenue and net income for the four quarters ended on or before April 30, 2022. Market value as of Oct. 17, 2022.
Fastest-Growing Companies
Revenue 3 Yr Growth Rank
72
Revenue 3 Yr Annual Growth Rate
24%
EPS 3 Yr Growth Rank
49
EPS 3 Yr Annual Growth Rate
62%
Total Return 3 Yr Rank
51
Total Return 3 Yr Annual Rate (Through June 30, 2022)
26%
Beat S&P 500 3 Yr Return (35.2%)
no
Current Streak
-
Years on List
1
Sector
Health Care
Key Financials (Last Fiscal Year)
$ millions
% change
Revenues ($M)
$3,998
29.2%
Profits ($M)
$585
165.1%
Assets ($M)
$9,112
-
Total Stockholder Equity ($M)
$4,274
-
Profit Ratios
Profit as % of Revenues
14.6%
Profits as % of Assets
6.4%
Profits as % of Stockholder Equity
13.7%
Earnings Per Share (Last Fiscal Year)
Earnings Per Share ($)
311
EPS % Change (from 2020)
172.8%
EPS % Change (5 year annual rate)
28.4%
EPS % Change (10 year annual rate)
-
Total Return
Total Return to Investors (2021)
23%
Total Return to Investors (5 year, annualized)
36.6%
Total Return to Investors (10 year, annualized)
-
